Company Analysis

ENDRA Life Sciences Inc. (NDRA)

Nasdaq: NDRA · Electromedical & Electrotherapeutic Apparatus · Ann Arbor, MI · filing with the SEC since 2016
Grade3.0
◀ Past 1.5● Present 4.2▶ Future 2.9
4 est.

Who runs ENDRA Life Sciences Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Tokman Alexander Y
Chief Executive Officer. First filing May 2017, latest Mar 4, 2026, 4 filings in all.
Officers reporting now
2
of 5 people with a filing in the last fifteen months
Directors reporting now
3
11 people on the record since 2017
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Tokman Alexander YChief Executive OfficerMay 2017Mar 4, 2026none
Jacroux RichardChief Financial OfficerAug 2024Mar 4, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Basenese LoudirectorApr 2020Jan 23, 2026none
Digiandomenico AnthonydirectorMay 2017Jan 23, 2026none
Harsh MichaeldirectorMay 2017Jan 23, 2026none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton NDRA · research, not advice